Silex Systems Ltd. engages in the development and commercialization of laser uranium enrichment technology. The company is headquartered in Sydney, New South Wales. The firm is focused on the commercialization of its Separation of Isotopes by Laser EXcitation (SILEX) laser enrichment technology for application to uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies). Its segments include Silex Systems, Translucent and Silex USA. Silex Systems is based in New South Wales and Translucent and Silex USA are based in North Carolina. The SILEX technology has been under development for uranium enrichment jointly with exclusive licensee Global Laser Enrichment LLC. The company is also focused on the development of additional commercial applications of the SILEX technology, including the production of Zero-Spin Silicon for the emerging technology of silicon-based quantum computing. The company has an interest in a semiconductor technology known as cREO through its ownership of subsidiary Translucent Inc.
Follow-Up Questions
What is Silex Systems Ltd (SILXF)'s P/E Ratio?
The P/E ratio of Silex Systems Ltd is N/A
What is the price performance of SILXF stock?
The current price of SILXF is 3.72, it has decreased 0% in the last trading day.
What is Silex Systems Ltd market cap?
Silex Systems Ltd's current market cap is $1
Is Silex Systems Ltd a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Silex Systems Ltd, including 1 strong buy, 4 buy, 1 hold, 0 sell, and 1 strong sell